SCHEMBL14329611

SCHEMBL14329611

c1ccc(-c2cc(-c3ccccc3)cc(-n3c4ccncc4c4c5ccc6cc7c(c8ccc(cc43)c5c68)c3cnccc3n7-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK10 P53779 1/20 0.39
▸ CYP19A1 P11511 1/20 0.36
▸ TNF P01375 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ TOP2A P11388 1/20 0.35
▸ CDC7 O00311 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ DHODH Q02127 1/20 0.33
▸ HASPIN Q8TF76 1/20 0.33
▸ PRKCZ Q05513 1/20 0.33
▸ PRKD2 Q9BZL6 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ CSNK2A2 P19784 1/20 0.33
▸ CSNK2B P67870 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NOTUM Q6P988 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14329646 0.92 KCNH2 (0.34) MAPK10CYP19A1TOP2ACDC7CDK2
SCHEMBL14330548 0.90 TNF (0.36) MAPK10CYP19A1TNFATMTOP2A
SCHEMBL16356762 0.85 CYP19A1 (0.41) MAPK10CYP19A1TNFATMCDC7
SCHEMBL16356759 0.85 CYP19A1 (0.41) MAPK10CYP19A1TNFATMCDC7
SCHEMBL14329624 0.84 TOP2A (0.42) ATMTOP2A
SCHEMBL14329621 0.84 MAPK10 (0.39) MAPK10TNFATMTOP2ACDC7
SCHEMBL15832254 0.83 MAPK10 (0.40) MAPK10CYP19A1TNFATMCDC7
SCHEMBL14329649 0.83 MAPK10 (0.42) MAPK10CYP19A1TOP2A
SCHEMBL14329625 0.82 CDK4 (0.39) MAPK10TOP2ADHODHMEN1HSP90AA1
SCHEMBL13866692 0.82 CYP19A1 (0.41) MAPK10CYP19A1TNFATMCDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771844-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-07-08 — — US disclosed
US-8771844-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-07-08 — — US disclosed
US-20120326135-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed
US-20120326135-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120326135-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND DDT, DRD1, HTR3D MAPK10 3300/4885CYP19A1 57/4885TNF 1386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback